Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) soared at $31.86, representing a gain of 72.9%. On Tue 08 Sep 20, ITCI:NASDAQ hit a New 2-Week Intraday High of $18.93. The stock appeared on our News Catalysts scanner on Wed 09 Sep 20 at 05:15 PM in the 'PUBLIC OFFERING' category. From Tue 25 Aug 20, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue 23 Jun 20 at $27.65 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)
Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
Top 10 Gainers:
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 72.87%
- Superconductor Technologies Inc. (SCON:NASDAQ), 44.92%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 43.66%
- Watford Holdings Ltd. (WTRE:NASDAQ), 24.79%
- Kaixin Auto Holdings (KXIN:NASDAQ), 24.31%
- HOFV (HOFV:NASDAQ), 22.67%
- AMYT (AMYT:NASDAQ), 21.84%
- Precipio, Inc. (PRPO:NASDAQ), 21.19%
- 500.com Limited (WBAI:NYSE), 20.9%
- Astrotech Corporation (ASTC:NASDAQ), 20.47%